AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35787487 — intervention group
Group type: EXPERIMENTAL
Intervention: MinSafeStart (MSS) mobile app
Number of subjects: 268
Study 35787487 — intervention group
Group type: COMPARATOR
Intervention: Standard maternal care
Number of subjects: 268
Study 34537744 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathyroid steroid injections
Number of subjects: 32
Study 34537744 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisone
Number of subjects: 32
Study 32718924 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG) with glucose metre, blood test strips, logbook, waste management box, and training in addition to usual care
Number of subjects: 0
Study 32718924 — intervention group
Group type: COMPARATOR
Intervention: Usual care (clinical consultations and routine monthly follow-up)
Number of subjects: 0
Study 35388281 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (article plus drawings)
Number of subjects: 60
Study 35388281 — intervention group
Group type: COMPARATOR
Intervention: Group A (only article)
Number of subjects: 60
Study 35431754 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 42
Study 35431754 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 42
Study 32943115 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine (0.1 ml of resuspended BCG vaccine administered intradermally)
Number of subjects: 1500
Study 32943115 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.1 ml of sterile 0.9% NaCl solution administered intradermally)
Number of subjects: 1500
Study 35996694 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional IMRT
Number of subjects: 100
Study 35996694 — intervention group
Group type: COMPARATOR
Intervention: Three-dimensional conformal radiotherapy (control)
Number of subjects: 100
Study 32796456 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-myofascial release therapy using the INYBI tool
Number of subjects: 58
Study 32796456 — intervention group
Group type: COMPARATOR
Intervention: Myofascial release therapy (MRT) of the suboccipital muscles
Number of subjects: 58
Study 34954424 — intervention group
Group type: EXPERIMENTAL
Intervention: Bethanechol (25 mg, 2 times daily)
Number of subjects: 50
Study 34954424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34954424 — intervention group
Group type: EXPERIMENTAL
Intervention: Bethanechol (for patients receiving 131I dose > 125mCi)
Number of subjects: 50
Study 32020168 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified dairy diet (SFA-reduced, MUFA-enriched)
Number of subjects: 54
Study 32020168 — intervention group
Group type: COMPARATOR
Intervention: Conventional dairy diet (control)
Number of subjects: 54
Study 36017021 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided laparoscopic radical gastrectomy with the FBP reconstruction algorithm
Number of subjects: 56
Study 36017021 — intervention group
Group type: COMPARATOR
Intervention: CT-guided laparoscopic radical gastrectomy (control group)
Number of subjects: 56
Study 34871488 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly combined injectable contraceptives (CIC)
Number of subjects: 124
Study 34871488 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive pills (COC)
Number of subjects: 124
Study 34871488 — intervention group
Group type: COMPARATOR
Intervention: Copper intrauterine device (IUD)
Number of subjects: 124
Study 33988887 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Thiamidol applied twice a day for 90 days
Number of subjects: 50
Study 33988887 — intervention group
Group type: COMPARATOR
Intervention: 4% hydroquinone cream applied at bedtime for 90 days
Number of subjects: 50
Study 33988887 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Thiamidol
Number of subjects: 50
Study 33988887 — intervention group
Group type: COMPARATOR
Intervention: 4% hydroquinone cream
Number of subjects: 50
Study 32191598 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone administration (10 mg daily for 10 weeks)
Number of subjects: 35
Study 33075840 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high-frequency oscillatory ventilation (NHFOV)
Number of subjects: 27
Study 32057739 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8mg
Number of subjects: 0
Study 32057739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32755441 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving, Story-bridge mental health literacy programme (3-hour duration)
Number of subjects: 140
Study 32755441 — intervention group
Group type: COMPARATOR
Intervention: Plain language basic brochure about mental health issues
Number of subjects: 140
Study 35606235 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐268019‐b recombinant protein vaccine (5 μg)
Number of subjects: 60
Study 35606235 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐268019‐b recombinant protein vaccine (10 μg)
Number of subjects: 60
Study 35606235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33394391 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-30% fly ash amended soil
Number of subjects: 0
Study 33394391 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-50% fly ash amended soil
Number of subjects: 0
Study 34999764 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin combined with elastic band exercise
Number of subjects: 136
Study 34999764 — intervention group
Group type: COMPARATOR
Intervention: Control group (CHF community care)
Number of subjects: 136
Study 34912887 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality nursing mode
Number of subjects: 72
Study 34912887 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing mode (Control)
Number of subjects: 72
Study 32057612 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple Head Extension (SHE)
Number of subjects: 100
Study 32057612 — intervention group
Group type: COMPARATOR
Intervention: Flexion Position (FP)
Number of subjects: 100
Study 32057612 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SHE and FP
Number of subjects: 100
Study 32016310 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron isomaltoside, 1000 mg on day 0
Number of subjects: 245
Study 32016310 — intervention group
Group type: COMPARATOR
Intervention: Ferric carboxymaltose, 750 mg infused on days 0 and 7
Number of subjects: 245
Study 34428717 — intervention group
Group type: EXPERIMENTAL
Intervention: ADD group (n = 15) consuming pecans as part of a free-living diet
Number of subjects: 47
Study 34428717 — intervention group
Group type: EXPERIMENTAL
Intervention: SUB group (n = 16) substituting pecans for isocaloric foods from their habitual diet
Number of subjects: 47
Study 34428717 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 47
Study 33031156 — intervention group
Group type: EXPERIMENTAL
Intervention: Facility-based screening and contact investigation of newly identified TB cases
Number of subjects: 2179
Study 36058174 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 108
Study 36058174 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmentectomy
Number of subjects: 108
Study 34422243 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography based on deep learning algorithm (observation group)
Number of subjects: 80
Study 34422243 — intervention group
Group type: COMPARATOR
Intervention: Routine echocardiography (control group)
Number of subjects: 80
Study 33308929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Number of subjects: 31
Study 33308929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Practice (MP)
Number of subjects: 31
Study 33308929 — intervention group
Group type: COMPARATOR
Intervention: Control group (relaxation intervention)
Number of subjects: 31
Study 32281738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 0
Study 32281738 — intervention group
Group type: COMPARATOR
Intervention: Placebo juice
Number of subjects: 0
Study 35897147 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-aging daily serum (AADS) containing sunflower sprout extract (SSE), used twice daily for 7 days
Number of subjects: 28
Study 35897147 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-aging daily serum (AADS) in combination with anti-aging facial moisturizer (AAFM), used twice daily for 7 days
Number of subjects: 28
Study 35897147 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study 34326043 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole 18 mg/kg two times per day (36 mg/kg/day) for 3 months
Number of subjects: 158
Study 34326043 — intervention group
Group type: COMPARATOR
Intervention: Placebo two times per day for 3 months
Number of subjects: 158
Study 32616067 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily hydroxychloroquine
Number of subjects: 1200
Study 32616067 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly hydroxychloroquine
Number of subjects: 1200
Study 32616067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study 35287641 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + minocycline hydrochloride (Exp 1)
Number of subjects: 92
Study 35287641 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + 809 nm diode laser + minocycline hydrochloride (Exp 2)
Number of subjects: 92
Study 35287641 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planning (SRP) (Control group)
Number of subjects: 92
Study 32425361 — intervention group
Group type: EXPERIMENTAL
Intervention: Lianhuaqingwen capsules (4 capsules, thrice daily for 14 days)
Number of subjects: 284
Study 32425361 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment alone
Number of subjects: 284
Study 33084049 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectus femoris transfer (RFT) as part of single-event multilevel surgery (SEMLS)
Number of subjects: 129
Study 33084049 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RFT)
Number of subjects: 129
Study 35397305 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial release technique in addition to conventional physiotherapy
Number of subjects: 30
Study 35397305 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (hot pack, interferential current, exercise program)
Number of subjects: 30
Study 34325942 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal fiber-splitting capsulotomy approach (FSC)
Number of subjects: 24
Study 34325942 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure with suture anchors in the FSC group
Number of subjects: 24
Study 34325942 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure with standard running suture in the FSC group
Number of subjects: 24
Study 34325942 — intervention group
Group type: COMPARATOR
Intervention: Dorsal window approach
Number of subjects: 24
Study 32336645 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide plus ADT
Number of subjects: 1150
Study 32336645 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 1150
Study 35708181 — intervention group
Group type: EXPERIMENTAL
Intervention: LYR‐210 (7500 µg)
Number of subjects: 24
Study 35708181 — intervention group
Group type: EXPERIMENTAL
Intervention: LYR‐210 (2500 µg)
Number of subjects: 24
Study 34114120 — intervention group
Group type: EXPERIMENTAL
Intervention: Thallium (Tl)
Number of subjects: 100
Study 34114120 — intervention group
Group type: EXPERIMENTAL
Intervention: Arsenic (As)
Number of subjects: 100
Study 34114120 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadmium (Cd)
Number of subjects: 100
Study 34114120 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead (Pb)
Number of subjects: 100
Study 34114120 — intervention group
Group type: EXPERIMENTAL
Intervention: Mercury (Hg)
Number of subjects: 100
Study 34114120 — intervention group
Group type: EXPERIMENTAL
Intervention: Beryllium (Be)
Number of subjects: 100
Study 34114120 — intervention group
Group type: EXPERIMENTAL
Intervention: Nickel (Ni)
Number of subjects: 100
Study 34114120 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium (Se)
Number of subjects: 100
Study 35511431 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent admixture vaccine
Number of subjects: 0
Study 35511431 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetravalent dengue vaccine (TV005)
Number of subjects: 0
Study 35511431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35511431 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-challenge response
Number of subjects: 0
Study 32781898 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander Intervention Model (BIM) informed factsheet
Number of subjects: 281
Study 32781898 — intervention group
Group type: COMPARATOR
Intervention: Standard factsheet about suicide and mental health
Number of subjects: 281
Study 34709008 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic learning curriculum (ELC) with spectrogram monitors
Number of subjects: 39
Study 34709008 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard residency curriculum without monitors)
Number of subjects: 39
Study 34709008 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic learning curriculum (ELC)
Number of subjects: 39
Study 34709008 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard residency curriculum)
Number of subjects: 39
Study 34709008 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients cared for by ELC group
Number of subjects: 39
Study 34709008 — intervention group
Group type: COMPARATOR
Intervention: Patients cared for by control group
Number of subjects: 39
Study 32015556 — intervention group
Group type: EXPERIMENTAL
Intervention: bNAb therapy during ART interruption
Number of subjects: 9
Study 35005990 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline-based placebo (PBO; 99.45% PBS)
Number of subjects: 233
Study 35005990 — intervention group
Group type: COMPARATOR
Intervention: Sham (dry needle)
Number of subjects: 233
Study 33812991 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health support for diabetes self-care for 12 months
Number of subjects: 0
Study 33812991 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0
Study 33812991 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health support for diabetes self-care
Number of subjects: 0
Study 36206092 — intervention group
Group type: COMPARATOR
Intervention: G3 culture medium
Number of subjects: 120
Study 36206092 — intervention group
Group type: COMPARATOR
Intervention: K-SICM culture medium
Number of subjects: 120
Study 33657181 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotating antibiotic therapy
Number of subjects: 0
Study 33657181 — intervention group
Group type: COMPARATOR
Intervention: Presence of bacteriuria
Number of subjects: 0
Study 35477817 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond (CU)
Number of subjects: 18
Study 35477817 — intervention group
Group type: EXPERIMENTAL
Intervention: iBOND Universal (IU)
Number of subjects: 18
Study 35477817 — intervention group
Group type: EXPERIMENTAL
Intervention: G-Premio Bond (GP)
Number of subjects: 18
Study 33221262 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin/Ezetimibe combination
Number of subjects: 1873
Study 33221262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1873
Study 33221262 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline hyponatremia
Number of subjects: 1873
Study 33221262 — intervention group
Group type: EXPERIMENTAL
Intervention: Incident hyponatremia
Number of subjects: 1873
Study 33221262 — intervention group
Group type: COMPARATOR
Intervention: Normonatremia
Number of subjects: 1873
Study 32421288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 34
Study 32421288 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 34
Study 33831316 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV treatment prescribed
Number of subjects: 177
Study 33831316 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV treatment initiated
Number of subjects: 177
Study 33831316 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttreatment undetected HCV viral load
Number of subjects: 177
Study 33046009 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow-restorative yoga intervention (twice weekly for 1 hour for 12 weeks)
Number of subjects: 38
Study 33046009 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintaining normal daily routine)
Number of subjects: 38
Study 35421008 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC‐201 infusion (up to 10 bags, equivalent to 3 units erythrocytes)
Number of subjects: 688
Study 35421008 — intervention group
Group type: COMPARATOR
Intervention: Erythrocyte transfusion (up to 3 units)
Number of subjects: 688
Study 35421008 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC‐201 infusion
Number of subjects: 688
Study 35421008 — intervention group
Group type: COMPARATOR
Intervention: Erythrocyte transfusion
Number of subjects: 688
Study 34800417 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (33,000 IU intravenously for 3 days)
Number of subjects: 108
Study 34800417 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenously for 3 days)
Number of subjects: 108
Study 33308110 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative mind-body-medicine group program
Number of subjects: 57
Study 36469000 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 plus best standard of care (BSoC)
Number of subjects: 831
Study 36469000 — intervention group
Group type: COMPARATOR
Intervention: BSoC alone
Number of subjects: 831
Study 33893449 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary changes in IMIDs
Number of subjects: 11230
Study 33893449 — intervention group
Group type: COMPARATOR
Intervention: Dietary changes in Inflammatory bowel diseases
Number of subjects: 11230
Study 33893449 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable reduction in Crohn’s Disease
Number of subjects: 11230
Study 33893449 — intervention group
Group type: EXPERIMENTAL
Intervention: Food groups associated with disease severity in IMIDs
Number of subjects: 11230
Study 34058654 — intervention group
Group type: EXPERIMENTAL
Intervention: Early onset (EO) patients with early non-improvement after 2 weeks of therapy (<20% improvement)
Number of subjects: 889
Study 34058654 — intervention group
Group type: COMPARATOR
Intervention: Late onset (LO) patients
Number of subjects: 889
Study 34058654 — intervention group
Group type: EXPERIMENTAL
Intervention: Early onset (EO) patients
Number of subjects: 889
Study 34058654 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolytes in early onset (EO) patients
Number of subjects: 889
Study 32801202 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg elemental iron as ferrous sulfate
Number of subjects: 480
Study 32801202 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 mg ferrous bisglycinate
Number of subjects: 480
Study 32801202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study 34221273 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-surgical percutaneous dilatational tracheostomy (SSPDT)
Number of subjects: 160
Study 34221273 — intervention group
Group type: COMPARATOR
Intervention: Conventional percutaneous dilatational tracheostomy (CPDT)
Number of subjects: 160
Study 33890342 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat‐killed Gordonia bronchialis (GB)
Number of subjects: 17
Study 33890342 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat‐killed Rhodococcus coprophilus (RC)
Number of subjects: 17
Study 33890342 — intervention group
Group type: EXPERIMENTAL
Intervention: GB/RC combination
Number of subjects: 17
Study 33890342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 32586741 — intervention group
Group type: COMPARATOR
Intervention: Gelfoam
Number of subjects: 82
Study 32586741 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable Synthetic Polyurethane Foam (BSPF)
Number of subjects: 82
Study 32207836 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral naloxone coadministration with ticagrelor and morphine
Number of subjects: 0
Study 32207836 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor and morphine without naloxone
Number of subjects: 0
Study 33990490 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence Clubs (ACs)
Number of subjects: 569
Study 33990490 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 569
Study 35961757 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking (NW)
Number of subjects: 130
Study 35961757 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 130
Study 35961757 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity continuous training (MICT)
Number of subjects: 130
Study 35961757 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (HIIT, MICT, NW)
Number of subjects: 130
Study 33189483 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week nutritional prehabilitation program
Number of subjects: 40
Study 33189483 — intervention group
Group type: COMPARATOR
Intervention: 1-week nutritional prehabilitation program
Number of subjects: 40
Study 33051342 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-1/PD-L1 inhibitors (monotherapy)
Number of subjects: 109
Study 34854214 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at Neiguan (PC6) and Shenmen (HT7) acupoints thrice a day for 2 days
Number of subjects: 100
Study 34854214 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 100
Study 32853647 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 25
Study 32853647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32493473 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic donor CD362 enriched human umbilical cord derived mesenchymal stromal cells (REALIST ORBCEL‐C)
Number of subjects: 60
Study 32493473 — intervention group
Group type: COMPARATOR
Intervention: Plasma‐Lyte 148 Solution for Infusion (200mls)
Number of subjects: 60
Study 35618613 — intervention group
Group type: EXPERIMENTAL
Intervention: I Pass the Baton (IPB) methodology; face-to-face training session, training on how to use the IPB, inserting the IPB chart into the patient file, training leaflet, and installing a poster in the ward.
Number of subjects: 65